OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New Therapies for Castration-Resistant Prostate Cancer
Dan L. Longo
New England Journal of Medicine (2010) Vol. 363, Iss. 5, pp. 479-481
Closed Access | Times Cited: 128
Dan L. Longo
New England Journal of Medicine (2010) Vol. 363, Iss. 5, pp. 479-481
Closed Access | Times Cited: 128
Showing 1-25 of 128 citing articles:
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Emmanuel S. Antonarakis, Changxue Lu, Hao Wang, et al.
New England Journal of Medicine (2014) Vol. 371, Iss. 11, pp. 1028-1038
Open Access | Times Cited: 2488
Emmanuel S. Antonarakis, Changxue Lu, Hao Wang, et al.
New England Journal of Medicine (2014) Vol. 371, Iss. 11, pp. 1028-1038
Open Access | Times Cited: 2488
Therapeutic cancer vaccines: past, present, and future.
Chunqing Guo, Masoud H. Manjili, John R. Subjeck, et al.
Europe PMC (PubMed Central) (2013) Vol. 119, pp. 421-75
Open Access | Times Cited: 558
Chunqing Guo, Masoud H. Manjili, John R. Subjeck, et al.
Europe PMC (PubMed Central) (2013) Vol. 119, pp. 421-75
Open Access | Times Cited: 558
Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase
Luc Pilotte, Pierre Larrieu, Vincent Stroobant, et al.
Proceedings of the National Academy of Sciences (2012) Vol. 109, Iss. 7, pp. 2497-2502
Open Access | Times Cited: 533
Luc Pilotte, Pierre Larrieu, Vincent Stroobant, et al.
Proceedings of the National Academy of Sciences (2012) Vol. 109, Iss. 7, pp. 2497-2502
Open Access | Times Cited: 533
Engineering Nano‐ and Microparticles to Tune Immunity
James J. Moon, Bonnie Huang, Darrell J. Irvine
Advanced Materials (2012) Vol. 24, Iss. 28, pp. 3724-3746
Open Access | Times Cited: 373
James J. Moon, Bonnie Huang, Darrell J. Irvine
Advanced Materials (2012) Vol. 24, Iss. 28, pp. 3724-3746
Open Access | Times Cited: 373
Therapeutic cancer vaccines: are we there yet?
Christopher A. Klebanoff, Nicolas Acquavella, Zhiya Yu, et al.
Immunological Reviews (2010) Vol. 239, Iss. 1, pp. 27-44
Open Access | Times Cited: 272
Christopher A. Klebanoff, Nicolas Acquavella, Zhiya Yu, et al.
Immunological Reviews (2010) Vol. 239, Iss. 1, pp. 27-44
Open Access | Times Cited: 272
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Chadi Nabhan
New England Journal of Medicine (2010) Vol. 363, Iss. 20, pp. 1966-1968
Closed Access | Times Cited: 209
Chadi Nabhan
New England Journal of Medicine (2010) Vol. 363, Iss. 20, pp. 1966-1968
Closed Access | Times Cited: 209
Antigen-specific vaccines for cancer treatment
Maria Tagliamonte, Annacarmen Petrizzo, Maria Lina Tornesello, et al.
Human Vaccines & Immunotherapeutics (2014) Vol. 10, Iss. 11, pp. 3332-3346
Open Access | Times Cited: 145
Maria Tagliamonte, Annacarmen Petrizzo, Maria Lina Tornesello, et al.
Human Vaccines & Immunotherapeutics (2014) Vol. 10, Iss. 11, pp. 3332-3346
Open Access | Times Cited: 145
Interdisciplinary Critique of Sipuleucel-T as Immunotherapy in Castration-Resistant Prostate Cancer
M. L. Huber, Laura Haynes, CC Parker, et al.
JNCI Journal of the National Cancer Institute (2012) Vol. 104, Iss. 4, pp. 273-279
Open Access | Times Cited: 145
M. L. Huber, Laura Haynes, CC Parker, et al.
JNCI Journal of the National Cancer Institute (2012) Vol. 104, Iss. 4, pp. 273-279
Open Access | Times Cited: 145
Cancer Immunotherapy
Robert O. Dillman
Cancer Biotherapy and Radiopharmaceuticals (2011) Vol. 26, Iss. 1, pp. 1-64
Closed Access | Times Cited: 126
Robert O. Dillman
Cancer Biotherapy and Radiopharmaceuticals (2011) Vol. 26, Iss. 1, pp. 1-64
Closed Access | Times Cited: 126
Association of AR-V7 and Prostate-Specific Antigen RNA Levels in Blood with Efficacy of Abiraterone Acetate and Enzalutamide Treatment in Men with Prostate Cancer
Fangfang Qu, Wanling Xie, Mari Nakabayashi, et al.
Clinical Cancer Research (2016) Vol. 23, Iss. 3, pp. 726-734
Open Access | Times Cited: 106
Fangfang Qu, Wanling Xie, Mari Nakabayashi, et al.
Clinical Cancer Research (2016) Vol. 23, Iss. 3, pp. 726-734
Open Access | Times Cited: 106
mRNA vaccine CV9103 and CV9104 for the treatment of prostate cancer
Steffen Rausch, Christian Schwentner, Arnulf Stenzl, et al.
Human Vaccines & Immunotherapeutics (2014) Vol. 10, Iss. 11, pp. 3146-3152
Open Access | Times Cited: 99
Steffen Rausch, Christian Schwentner, Arnulf Stenzl, et al.
Human Vaccines & Immunotherapeutics (2014) Vol. 10, Iss. 11, pp. 3146-3152
Open Access | Times Cited: 99
Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma
Marijo Bilušić, Christopher R. Heery, Philip M. Arlen, et al.
Cancer Immunology Immunotherapy (2013) Vol. 63, Iss. 3, pp. 225-234
Open Access | Times Cited: 97
Marijo Bilušić, Christopher R. Heery, Philip M. Arlen, et al.
Cancer Immunology Immunotherapy (2013) Vol. 63, Iss. 3, pp. 225-234
Open Access | Times Cited: 97
Cancer Immunotherapy: Sipuleucel‐T and Beyond
Aimee Hammerstrom, Diana H. Cauley, Bradley J. Atkinson, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2011) Vol. 31, Iss. 8, pp. 813-828
Open Access | Times Cited: 96
Aimee Hammerstrom, Diana H. Cauley, Bradley J. Atkinson, et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2011) Vol. 31, Iss. 8, pp. 813-828
Open Access | Times Cited: 96
Immunotherapy for the treatment of prostate cancer
Giuseppe Di Lorenzo, Carlo Buonerba, Philip W. Kantoff
Nature Reviews Clinical Oncology (2011) Vol. 8, Iss. 9, pp. 551-561
Closed Access | Times Cited: 96
Giuseppe Di Lorenzo, Carlo Buonerba, Philip W. Kantoff
Nature Reviews Clinical Oncology (2011) Vol. 8, Iss. 9, pp. 551-561
Closed Access | Times Cited: 96
Immunotherapy for Metastatic Solid Cancers
Simon Turcotte, Steven A. Rosenberg
Advances in Surgery (2011) Vol. 45, Iss. 1, pp. 341-360
Open Access | Times Cited: 80
Simon Turcotte, Steven A. Rosenberg
Advances in Surgery (2011) Vol. 45, Iss. 1, pp. 341-360
Open Access | Times Cited: 80
Targeting NF-kappa B Signaling by Artesunate Restores Sensitivity of Castrate-Resistant Prostate Cancer Cells to Antiandrogens
Jessica J. Nunes, Swaroop Kumar Pandey, Anjali Yadav, et al.
Neoplasia (2017) Vol. 19, Iss. 4, pp. 333-345
Open Access | Times Cited: 79
Jessica J. Nunes, Swaroop Kumar Pandey, Anjali Yadav, et al.
Neoplasia (2017) Vol. 19, Iss. 4, pp. 333-345
Open Access | Times Cited: 79
Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer
Emmanuel S. Antonarakis, Karim Boudadi
Clinical Medicine Insights Oncology (2016), pp. 1-1
Open Access | Times Cited: 70
Emmanuel S. Antonarakis, Karim Boudadi
Clinical Medicine Insights Oncology (2016), pp. 1-1
Open Access | Times Cited: 70
A comprehensive review of immunotherapies in prostate cancer
Manuel Caitano Maia, Aaron R. Hansen
Critical Reviews in Oncology/Hematology (2017) Vol. 113, pp. 292-303
Closed Access | Times Cited: 62
Manuel Caitano Maia, Aaron R. Hansen
Critical Reviews in Oncology/Hematology (2017) Vol. 113, pp. 292-303
Closed Access | Times Cited: 62
Targeting GRP78-dependent AR-V7 protein degradation overcomes castration-resistance in prostate cancer therapy
Yuning Liao, Yuan Liu, Xiaohong Xia, et al.
Theranostics (2020) Vol. 10, Iss. 8, pp. 3366-3381
Open Access | Times Cited: 60
Yuning Liao, Yuan Liu, Xiaohong Xia, et al.
Theranostics (2020) Vol. 10, Iss. 8, pp. 3366-3381
Open Access | Times Cited: 60
Intensity Modulated Radiation Therapy Dose Painting for Localized Prostate Cancer Using 11C-choline Positron Emission Tomography Scans
Joe H. Chang, Daryl Lim Joon, Sze Ting Lee, et al.
International Journal of Radiation Oncology*Biology*Physics (2012) Vol. 83, Iss. 5, pp. e691-e696
Open Access | Times Cited: 72
Joe H. Chang, Daryl Lim Joon, Sze Ting Lee, et al.
International Journal of Radiation Oncology*Biology*Physics (2012) Vol. 83, Iss. 5, pp. e691-e696
Open Access | Times Cited: 72
Resistance to Novel Antiandrogen Therapies in Metastatic Castration-Resistant Prostate Cancer
Karim Boudadi, Emmanuel S. Antonarakis
Clinical Medicine Insights Oncology (2016) Vol. 10s1
Open Access | Times Cited: 60
Karim Boudadi, Emmanuel S. Antonarakis
Clinical Medicine Insights Oncology (2016) Vol. 10s1
Open Access | Times Cited: 60
Materials based tumor immunotherapy vaccines
Aileen W. Li, David Mooney
Current Opinion in Immunology (2013) Vol. 25, Iss. 2, pp. 238-245
Open Access | Times Cited: 58
Aileen W. Li, David Mooney
Current Opinion in Immunology (2013) Vol. 25, Iss. 2, pp. 238-245
Open Access | Times Cited: 58
Self‐Assembly Protein Nanogels for Safer Cancer Immunotherapy
Alberto Purwada, Ye Tian, Weishan Huang, et al.
Advanced Healthcare Materials (2016) Vol. 5, Iss. 12, pp. 1413-1419
Open Access | Times Cited: 53
Alberto Purwada, Ye Tian, Weishan Huang, et al.
Advanced Healthcare Materials (2016) Vol. 5, Iss. 12, pp. 1413-1419
Open Access | Times Cited: 53
New and emerging agents for the treatment of castration-resistant prostate cancer
Celestia S. Higano, E. David Crawford
Urologic Oncology Seminars and Original Investigations (2011) Vol. 29, Iss. 6, pp. 1-8
Closed Access | Times Cited: 58
Celestia S. Higano, E. David Crawford
Urologic Oncology Seminars and Original Investigations (2011) Vol. 29, Iss. 6, pp. 1-8
Closed Access | Times Cited: 58
Active‐specific immunotherapy of human cancers with the heat shock protein Gp96—revisited
Marco Randazzo, Peter Terness, Gerhard Opelz, et al.
International Journal of Cancer (2011) Vol. 130, Iss. 10, pp. 2219-2231
Open Access | Times Cited: 56
Marco Randazzo, Peter Terness, Gerhard Opelz, et al.
International Journal of Cancer (2011) Vol. 130, Iss. 10, pp. 2219-2231
Open Access | Times Cited: 56
